Entera Bio Ltd. — Director's Dealing 2022

Jan 24, 2022

SEC Form 3/A — Form 3/A

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2022-01-01

Reporting Person: LIEBERMAN GERALD M (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares, par value NIS 0.0000769 per share	131918	Direct
Ordinary Shares, par value NIS 0.0000769 per share	1500	Indirect
Ordinary Shares, par value NIS 0.0000769 per share	1500	Indirect
Ordinary Shares, par value NIS 0.0000769 per share	1500	Indirect
Ordinary Shares, par value NIS 0.0000769 per share	1500	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$3.69	2023-04-06	Ordinary Shares, par value NIS 0.0000769 per share (147290)		Direct
Stock Option (right to buy)	$3.98	2029-01-17	Ordinary Shares, par value NIS 0.0000769 per share (33638)		Direct

Footnotes

F1: This Form 3 amendment is being filled to correct the original Form 3 filed on January 11, 2022. The original Form 3 inadvertently omitted ordinary shares indirectly held by the Reporting Person. These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2: This Form 3 amendment is being filled to correct the original Form 3 filed on January 11, 2022. The original Form 3 inadvertently omitted ordinary shares indirectly held by the Reporting Person. These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F3: This Form 3 amendment is being filled to correct the original Form 3 filed on January 11, 2022. The original Form 3 inadvertently omitted ordinary shares indirectly held by the Reporting Person. These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F4: This Form 3 amendment is being filled to correct the original Form 3 filed on January 11, 2022. The original Form 3 inadvertently omitted ordinary shares indirectly held by the Reporting Person. These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F5: The options vested ratably on a quarterly basis over a three-year period that commenced December 27, 2018.